CDP323 Biomarker Study

NCT00726648 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG: CDP323
DRUG: CDP323
DRUG: CDP323
DRUG: CDP323
DRUG: Placebo

Sponsor

UCB Pharma

Collaborators

[object Object]